High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

Por Philip, T., Dumont, J., Teillet, F., Maraninchi, D., Gorin, N. C., Kuentz, M., Harousseau, J. L., Marty, M., Pinkerton, R., Herve, P.
Publicado em 1986

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care.

Por Macquart-Moulin, G., Viens, P., Bouscary, M. L., Genre, D., Resbeut, M., Gravis, G., Camerlo, J., Maraninchi, D., Moatti, J. P.
Publicado em 1997

Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.

Por Richard, B., Launay-Iliadis, M. C., Iliadis, A., Just-Landi, S., Blaise, D., Stoppa, A. M., Viens, P., Gaspard, M. H., Maraninchi, D., Cano, J. P.
Publicado em 1992

Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients

Por Gonçalves, A, Esterni, B, Bertucci, F, Sauvan, R, Cubizolles, M, Granjeaud, S, Chabannon, C, Houvenaegel, G, Jacquemier, J, Meng, X-Y, Fung, ET, Birnbaum, D, Maraninchi, D, Viens, P, Borg, JP
Publicado no Breast Cancer Res (2005)

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

Por Chabannon, C., Cornetta, K., Lotz, J. P., Rosenfeld, C., Shlomchik, M., Yanovitch, S., Marolleau, J. P., Sledge, G., Novakovitch, G., Srour, E. F., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, D., Maraninchi, D., Mills, B., Kunkel, L., Oldham, F., Blaise, D., Viens, P.
Publicado em 1998